Arylamine N-acetyltransferases and drug response.

Authors:
Peter Meisel

Pharmacogenomics 2002 May;3(3):349-66

Department of Pharmacology, Ernst Moritz Arndt University Greifswald, F-Loeffler-Str. 23d, D-17487 Greifswald, Germany.

Arylamine N-acetyltransferases (NATs) play an important role in the interaction of competing metabolic pathways determining the fate of and response to xenobiotics as therapeutic drugs, occupational chemicals and carcinogenic substances. Individual susceptibility for drug response and possible adverse drug reactions are modulated by the genetic predisposition (manifested for example, by polymorphisms) and the phenotype of these enzymes. For all drugs metabolized by NATs, the impact of different in vivo enzyme activities is reviewed with regard to therapeutic use, prevention of side effects and possible indications for risk assessment by phenotyping and/or genotyping. As genes of NATs are susceptibility genes for multifactorial adverse effects and xenobiotic-related diseases, risk prediction can only be made possible by taking the complexity of events into consideration.

Download full-text PDF

Source
http://dx.doi.org/10.1517/14622416.3.3.349DOI Listing
May 2002
2 Reads

Publication Analysis

Top Keywords

arylamine n-acetyltransferases
8
drug response
8
genes nats
4
genetic predisposition
4
nats susceptibility
4
predisposition manifested
4
genotyping genes
4
example polymorphisms
4
manifested example
4
modulated genetic
4
polymorphisms phenotype
4
reactions modulated
4
susceptibility drug
4
effects indications
4
substances individual
4
response adverse
4
adverse drug
4
and/or genotyping
4
drug reactions
4
genes multifactorial
4

References

(Supplied by CrossRef)

Boenicke R et al.
Arch. Exp. Pathol. Pharmakol. 1953

Hughes HB et al.
Amer. Rec. Tubercul. 1954

Evans DAP et al.
UK 1993

Brockton N et al.
Am. J. Epidemiol. 2000

Grant DM et al.
Mutat. Res. 1997

Hanna PE et al.
San Diego, USA 1994

Similar Publications